Cargando…

CAR-T Cell Therapy and the Gut Microbiota

SIMPLE SUMMARY: CAR-T cell therapy has recently revolutionized the field of cancer therapeutics, especially for hematological malignancies, and is also evolving as an experimental therapeutic option for solid tumors. Despite the groundbreaking initial response rates, nearly half of CAR-T cell treate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asokan, Sahana, Cullin, Nyssa, Stein-Thoeringer, Christoph K., Elinav, Eran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913364/ https://www.ncbi.nlm.nih.gov/pubmed/36765752 http://dx.doi.org/10.3390/cancers15030794

Ejemplares similares

Time‐limited diets and the gut microbiota in cardiometabolic disease
por: Ratiner, Karina, et al.
Publicado: (2022)

Metabolites: messengers between the microbiota and the immune system
por: Levy, Maayan, et al.
Publicado: (2016)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Interaction between microbiota and immunity in health and disease
por: Zheng, Danping, et al.
Publicado: (2020)

Harnessing the Gut Microbiota to Potentiate the Efficacy of CAR T Cell Therapy
por: Gabrielli, Giulia, et al.
Publicado: (2023)

The Gut Microbiome and Individual-Specific Responses to Diet
por: Leshem, Avner, et al.
Publicado: (2020)

Gut microbiome and CAR-T therapy
por: Abid, Muhammad Bilal, et al.
Publicado: (2019)

Small Intestinal Microbiota Oscillations, Host Effects and Regulation—A Zoom into Three Key Effector Molecules
por: Ratiner, Karina, et al.
Publicado: (2023)

The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy
por: Schubert, Maria-Luisa, et al.
Publicado: (2021)

The gut microbiome in human immunodeficiency virus infection
por: Zilberman-Schapira, Gili, et al.
Publicado: (2016)

CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome
por: Levy, Maayan, et al.
Publicado: (2015)

Harnessing SmartPhones to Personalize Nutrition in a Time of Global Pandemic
por: Zmora, Niv, et al.
Publicado: (2021)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

Local and systemic effects of microbiome‐derived metabolites
por: Spivak, Igor, et al.
Publicado: (2022)

The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)
por: Boddy, Sarah L., et al.
Publicado: (2021)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

Use of Metatranscriptomics in Microbiome Research
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Inflammasome activation and regulation: toward a better understanding of complex mechanisms
por: Zheng, Danping, et al.
Publicado: (2020)

Utilization of Host and Microbiome Features in Determination of Biological Aging
por: Ratiner, Karina, et al.
Publicado: (2022)

Seatbelts in CAR therapy: How Safe Are CARS?
por: Minagawa, Kentaro, et al.
Publicado: (2015)

Donor T cells for CAR T cell therapy
por: Tang, Tiffany C. Y., et al.
Publicado: (2022)

Chronobiomics: The Biological Clock as a New Principle in Host–Microbial Interactions
por: Thaiss, Christoph A., et al.
Publicado: (2015)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Herrera, Lara, et al.
Publicado: (2021)

New development in CAR-T cell therapy
por: Wang, Zhenguang, et al.
Publicado: (2017)

Global Manufacturing of CAR T Cell Therapy
por: Levine, Bruce L., et al.
Publicado: (2016)

CAR T-Cell Therapy in Hematological Malignancies
por: Haslauer, Theresa, et al.
Publicado: (2021)

Gut Microbiota and Parkinson’s Disease: Implications for Faecal Microbiota Transplantation Therapy
por: Kang, Yongbo, et al.
Publicado: (2021)

New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
por: Innao, Vanessa, et al.
Publicado: (2020)

Gut Microbiota and Cancer: From Pathogenesis to Therapy
por: Vivarelli, Silvia, et al.
Publicado: (2019)

Engineering switchable and programmable universal CARs for CAR T therapy
por: Liu, Delong, et al.
Publicado: (2019)

Bile acids in glucose metabolism in health and disease
por: Shapiro, Hagit, et al.
Publicado: (2018)

The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018)

Role of the gut microbiota in nutrition and health
por: Valdes, Ana M, et al.
Publicado: (2018)

CAR-T Cell Therapy: From the Shop to Cancer Therapy
por: Uscanga-Palomeque, Ashanti Concepción, et al.
Publicado: (2023)

Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
por: Mhaidly, Rana, et al.
Publicado: (2020)

Intracellular bacteria in cancer—prospects and debates
por: Schorr, Lena, et al.
Publicado: (2023)

Human microbiome research: Growing pains and future promises
por: Puschhof, Jens, et al.
Publicado: (2023)

Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
por: Albinger, Nawid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4s2ogu9bf2q87m7q911egof32c